Estimates and analysis
Talenom is followed by Inderes, Danske Bank and Carnegie.
The estimates and analyses provided on this page are independent and impartial opinions of Inderes and Danske Bank. Talenom cannot influence the content of these analyses or the reliability of the information they contain. The information should not under any circumstances be regarded as investment advice.
Juha Kinnunen
040 778 1368
juha.kinnunen(at)inderes.fi
Daniel Lepistö
Phone: +358 44 512 1115
Email: daniel.lepisto@danskebank.com
Emil Immonen
Phone: +358 9 618 71 240
Email: emil.immonen@carnegie.fi
2021 | 2022 | 2023e | 2024e | 2025e | |
---|---|---|---|---|---|
Revenue (MEUR) | 82.8 | 104 | 126 | 144 | 163 |
Revenue growth (%) | 27.1 | 25.0 | 23,5 | 14.4 | 13.3 |
Operating profit, EBIT (MEUR) | 14.8 | 15.3 | 15.3 | 19.6 | 26.4 |
EBIT growth (%) | 14.6 | 8.0 | 0.3 | 27.9 | 34.7 |
Earnings per share (€) | 0.25 | 0.27 | 0.21 | 0.28 | 0.40 |
Dividend (€) | 0.17 | 0.18 | 0.19 | 0.20 | 0.21 |
Commissioned Research (published 26 October, 2022)
Commissioned Research (published 3 August, 2022)
Commissioned research (published 26 April, 2022)
Commissioned research (published 19 April, 2022)
Commissioned research (published 9 February, 2022)
Commissioned research (published 5 January, 2022)
Commissioned research (published 1 November, 2021
Commissioned research (published 3 August, 2021)
Commissioned research (published 27 April, 2021)
Commissioned research (published 9 February, 2021)
Commissioned research (published 26 October, 2020)
Commissioned research (published 3 August, 2020)
Commissioned research (published 27 April, 2020)
Commissioned research (published 18 March, 2020)